Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Clinical Study Initiated by Researchers on the Safety and Preliminary Efficacy of BGT007 in Treating Patients with Recurrent/refractory Gastrointestinal Malignancies

NCT06645301 is registered in ClinicalTrials.gov with BioSyngen Pte Ltd as lead sponsor.

NCT NCT06645301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06645301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Clinical Study Initiated by Researchers on the Safety and Preliminary Efficacy of BGT007 in Treating Patients with Recurrent/refractory Gastrointestinal Malignancies
Lead sponsor
BioSyngen Pte Ltd
Phase
Phase 1
Overall status
Not yet recruiting
Start date
November 30, 2024
Completion date
August 31, 2027
Enrollment
15 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, pancreatic cancer